Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.15
-5.43 (-3.58%)
At close: Oct 30, 2026, 4:00 PM EDT
148.00
+1.85 (1.27%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2.11 billion as of October 30, 2026. It is the 6,192nd most valuable company in the world and the 1,720th biggest in the United States. Its market cap has increased by 153.30% in one year.
Market Cap
2.11B
Enterprise Value
1.88B
1-Year Change
153.30%
Global Rank
Country Rank
#1,720 United States
Category
ChartMarket Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.11B, an increase of 1,362.66%. That is a compound annual growth rate of 319.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 2.11B | 69.97% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.18B |
| Maravai LifeSciences Holdings | 2.14B |
| Immunome | 2.13B |
| Septerna | 2.07B |
| Zymeworks | 2.06B |
| Lakefront Biotherapeutics NV | 2.04B |
| SELLAS Life Sciences Group | 2.03B |
| ADARx Pharmaceuticals | 2.01B |